Organization
Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany
9 abstracts
Abstract
First results of the NOGGO PERCEPTION: Phase II investigational study of pembrolizumab in combination with chemotherapy in platinum-sensitive recurrent low-grade serous ovarian cancer.Org: North-Eastern German Society of Gynaecological Oncology (NOGGO), Department of Gynecology with Center for Oncological Surgery, Charité-University Medicine of Berlin, Campus Virchow Klinikum, Berlin, Germany, North-Eastern-German Society of Gynaecological Oncology, Berlin, Germany, Kliniken Essen-Mitte, Department of Gynecology and Gynecological Oncology, Essen, Germany, Charité Universitätsmedizin Berlin and North Eastern German Society for Gynecologic Oncology (NOGGO), Berlin, Germany,
Abstract
First trial of chemotherapy de-escalation in ovarian cancer (OC): A phase III randomized, open label study of niraparib maintenance after carboplatin and paclitaxel in patients with optimally debulked advanced (homologous recombination deficient) HRD high-grade ovarian cancer in first line therapy (N-PLUS/NOGGO-ov53/ENGOT-ov62).Org: Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany, Stanford University School of Medicine, Institute for Biometry and Clinical Epidemiology, Hospital Universitario Virgen del Rocío, Sant'Anna Hospital,
Abstract
Patients with endometrial cancer: Expectations and preferences towards therapy and quality of life—First results of an international survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI).Org: Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany, Campus Virchow Klinikum, Charité - University Medicine of Berlin, Institute of Biometry and Clinical Epidemiology,
Abstract
Comprehensive HRD testing in epithelial ovarian cancer: A further step toward personalized therapy decisions.Org: Innsbruck Medical University; Department of Obstetrics and Gynecology, Innsbruck, Austria, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China, Innsbruck, Austria, Institute of Human Genetics, North-Eastern German Society of Gynaecological Oncology (NOGGO) and Department of Gynecology with Center for Oncological Surgery, Charité-University Medicine of Berlin, Campus Virchow Klinikum, Berlin, Germany,
Abstract
Incidence of metachronous peritoneal metastases for intrahepatic cholangiocarcinoma after curative resection: A single center cohort analysis.Org: Charité - Universitätsmedizin Berlin, Berlin, Germany, Chirurgische Klinik, Charité– Universitaetsmedizin Berlin, Medizinische Hochschule Hannover, Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany,
Abstract
Real world evidence on long-term survival of patients with endometrial cancer in Germany: Analysis of population-based cancer registry data on 49808 women.Org: Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany, Institute for Biometrics and Clinical Epidemiology, Charité - University Medicine Berlin, Charite University Hospital Campus Virchow, Campus Virchow Clinic,
Abstract
Sexuality as a prognostic factor: Results of an individual participant data NOGGO-meta-analysis of 1,041 recurrent ovarian cancer patients before starting chemotherapy.Org: Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany, Charité - University Medicine of Berlin, North-Eastern German Society of Gynaecological Oncology (NOGGO) and Department of Gynecology with Center for Oncological Surgery, Charité-University Medicine of Berlin, Campus Virchow Klinikum, Berlin, Germany,
Abstract
ASSESSMENT OF PARTICLE-ASSOCIATED REVERSE TRANSCRIPTASE IN PLASMA OF AUTOIMMUNE DISEASE PATIENTS WITH SCLERODERMA, SLE, OR SPONDYLITIS ANKYLOSANSOrg: Center for Biological Safety, Robert Koch-Institute, Rheumatology and Clinical Immunology, Biomedical Engineering, Vascular diseases, University Medical Center, Groningen, Netherlands, Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany, Berlin Heals,
Abstract
ANALYSIS OF BLOOD MONOCYTE TRANSCRIPTOMES AND BONE MARROW SAMPLES OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS REVEALS THEIR CHANGES RELATED TO ACTIVATION AND MYELOPOIESISOrg: Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany, Deutsches Rheumaforschungszentrum, Berlin,